Contents of this document
- Impact of the revision of medical service fees: medical insurance revenue fell by approximately ¥200,000 per resident per month immediately after the revision, but revenue per unit improved through various measures. The number of users began recovering from October after declining.
- Return to profitability: recovery in operating volume and adjustment of the balance between operating volume and staff numbers are required to return to profitability.
- Earnings and dividend forecasts: the immediate impact and winter bonuses have not been finalized, making reasonable calculations difficult. The forecasts will be announced once they can be calculated.
- Business plans from 2027 onward: the impact of the revision of medical service fees and facility development plans are under review, and the announcement timing is undetermined.
- Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited.
- Alliance with Sugi Holdings: joint development has been completed at 7 facilities, and approximately 10 facilities are under discussion.
- Equity offering: the company generally considers equity financing unnecessary, but will make a comprehensive decision based on financial indicators, market conditions and other factors.
- Recruitment: applications exceeded the number of available positions, and no facility opening has previously been delayed due to recruitment.
- Leased and company-owned facilities: approximately 90% of all facilities are operated under lease arrangements. The company plans to monetize its company-owned properties in the future.
- Optimization of residential rents and other charges
- Improvement in home-visit nursing productivity
- Improving the collection rate for Life Plan fees
- Sales initiatives prioritizing the recovery of operating volume
- Adjusting staff numbers in line with the recovery in operating volume
- Joint development and collaboration on hospice facilities with Sugi Holdings
- Decrease in medical insurance revenue per residentApproximately ¥200,000
- Decrease in the number of users from the end of June to the end of September162 people
- Increase in the number of users from the end of SeptemberApproximately 30
- Percentage of facilities operated under lease arrangementsApproximately 90%
| Item | Details |
|---|---|
| Document type | Summary of Q&A |
| Fiscal Period Covered | Q3 of the fiscal year ending December 2026 |
| Full-year earnings forecast | Withdrawn. To be announced again once reasonable figures can be calculated |
| Key KPIs | Indicator name Decrease in medical insurance revenue per resident / Value Approximately ¥200,000 / Year on year against the same period last year Not disclosed, Indicator name Decrease in the number of users from the end of June to the end of September / Value 162 people / Year on year against the same period last year Not disclosed, Indicator name Increase in the number of users from the end of September / Value Approximately 30 / Year on year against the same period last year Not disclosed, Indicator name Percentage of facilities operated under lease arrangements / Value Approximately 90% / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | The company explained the balance between revenue per resident, operating volume, occupancy rate and staff numbers. Revenue per unit improves each month, while operating volume has been recovering since October. |
| Assumptions Underlying the Business Outlook | The impact of the revision of medical service fees, the amount of the winter 2026 bonus and the certainty of facility opening plans are under review. Numerical assumptions: Not disclosed |
| Financial targets | The company cited the equity ratio and other factors as considerations in deciding whether to raise capital, but target and actual figures are Not disclosed |
| Annual Dividend | The dividend forecast has been withdrawn. Amount and breakdown: Not disclosed |
| Key points of the Q&A | Impact of the revision of medical service fees: medical insurance revenue fell by approximately ¥200,000 per resident per month immediately after the revision, but revenue per unit improved through various measures. The number of users began recovering from October after declining., Return to profitability: recovery in operating volume and adjustment of the balance between operating volume and staff numbers are required to return to profitability., Earnings and dividend forecasts: the immediate impact and winter bonuses have not been finalized, making reasonable calculations difficult. The forecasts will be announced once they can be calculated., Business plans from 2027 onward: the impact of the revision of medical service fees and facility development plans are under review, and the announcement timing is undetermined., Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited., Alliance with Sugi Holdings: joint development has been completed at 7 facilities, and approximately 10 facilities are under discussion., Equity offering: the company generally considers equity financing unnecessary, but will make a comprehensive decision based on financial indicators, market conditions and other factors., Recruitment: applications exceeded the number of available positions, and no facility opening has previously been delayed due to recruitment., Leased and company-owned facilities: approximately 90% of all facilities are operated under lease arrangements. The company plans to monetize its company-owned properties in the future. |
| New initiatives | Optimization of residential rents and other charges, Improvement in home-visit nursing productivity, Improving the collection rate for Life Plan fees, Sales initiatives prioritizing the recovery of operating volume, Adjusting staff numbers in line with the recovery in operating volume, Joint development and collaboration on hospice facilities with Sugi Holdings |
Items this document does not state (21)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company considers it difficult to calculate a reasonable earnings forecast at this time because revenue and earnings have been changing due to the impact of the revision of medical service fees and the amount of the winter 2026 bonus has not been finalized. For plans from 2027 onward, it stated that it needs to examine the impact of the fee revision and improve the certainty of its facility opening plans.